cyclosporine has been researched along with Arteriosclerosis in 84 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 58 (69.05) | 18.2507 |
2000's | 24 (28.57) | 29.6817 |
2010's | 2 (2.38) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gejyo, F; Imai, N; Ito, Y; Nakagawa, Y; Narita, I; Nishi, S; Saito, K; Takahashi, K; Tasaki, M | 1 |
Komiya, T; Muso, E | 1 |
Alsina, J; Fiol, C; Gil-Vernet, S; Gómez-Gerique, N; Grinyó, JM; Hurtado, I; Martínez Castelao, A; Ramos, R; Sabaté, I; Serón, D; Yzaguirre, MT | 1 |
Bussenius-Kammerer, M; Hohenberger, W; Kissler, H; Koch, CA; Müller, V; Ott, R; Reck, T | 1 |
Hakamata, Y; Inoue, S; Kaneko, T; Kobayashi, E; Morishita, Y; Shimizu, H; Tahara, K; Takahashi, M; Takeda, S; Takeyoshi, I | 1 |
Agca, E; Cantürk, F; Colak, T; Haberal, M; Ozdemir, FN; Sezer, S | 1 |
Aragona, M; Boggi, U; Coppelli, A; Del Prato, S; Donadio, F; Giannarelli, R; Marchetti, P; Mosca, F; Napoli, V; Paleologo, G; Rizzo, G; Tregnaghi, C | 1 |
Friedman, GS; Gioia, K; Jin, S; Knipp, GT; Mathis, AS; Minko, T; Rosenblatt, J; Serur, DS | 1 |
Friedman, GS; Gioia, K; Jin, S; Knipp, GT; Mathis, AS; Minko, T; Peng, F; Rosenblatt, J; Serur, DS | 1 |
Balling, R; Chilla, S; Gröne, HJ; Hartmann, N; Henger, A; Hoffmann, R; Joergensen, J; Kiss, E; Kretzler, M; Li, JP; Luckow, B; Maier, H; Nelson, PJ; Pérez de Lema, G; Pfeffer, K; Roth, L; Schlöndorff, D; Wieczorek, G; Wurst, W; Zerwes, HG | 1 |
Fujishiro, J; Hakamata, Y; Inoue, S; Kaneko, T; Kobayashi, E; Morishita, Y; Murakami, T; Shimizu, H; Takahashi, M; Takeda, S; Takeyoshi, I | 1 |
Augé, N; Elbaz, M; Escargueil-Blanc, I; Heniquez, A; Nègre-Salvayre, A; Salvayre, R; Thiers, JC; Vindis, C | 1 |
Amin, K; Bastani, B; Salinas-Madrigal, L | 1 |
Chmiel, B; Cierpka, L; Karkoszka, H; Wiecek, A | 1 |
Kotyla, PJ; Kucharz, EJ; Lewicki, M; Sliwińska-Kotyla, B | 1 |
Benediktsson, H; Davidoff, A; Paul, LC | 2 |
Boccagni, P; Emre, S; Jindal, RM; Miller, CM; Popescu, I; Schwartz, ME | 1 |
Häyry, PJ; Koskinen, PK; Lemström, KB | 1 |
Andersen, HO; Hansen, BF; Holm, P; Kjeldsen, K; Nordestgaard, BG; Stender, S | 1 |
Drew, AF; Tipping, PG | 1 |
Demacker, PN; Hilbrands, LB; Hoitsma, AJ; Koene, RA; Stalenhoef, AF | 1 |
Borge, M; Dahl, KJ; Hartmann, A; Holdaas, H; Pfister, P; Stenstrøm, J | 1 |
Daugherty, A; Roselaar, SE; Schonfeld, G | 1 |
Bellón, JM; Buján, MJ; Contreras, L; Dominguez, B; Ga-Honduvilla, N; Hernando, A; Jurado, F | 1 |
Fieguth, HG; Haverich, A; Heublein, B; Jurmann, M; Mügge, A; Oppelt, P; Wahlers, T | 1 |
Bonthuis, F; de Bruin, RW; Geerling, RA; Ijzermans, JN; Jeekel, J; Marquet, RL; Scheringa, M | 1 |
Andersen, HO; Kjeldsen, K; Madsen, G; Nordestgaard, BG; Stender, S | 1 |
Andersen, HO; Holm, P; Kjeldsen, K; Nordestgaard, BG; Stender, S | 1 |
Andersson, O; Björkhem, I; Diczfalusy, U; Duan, C; Lund, E; Sevastik, B; Xiu, RJ | 1 |
Petri, WA | 1 |
Andersen, HO; Hansen, BF; Kjeldsen, K; Madsen, G; Nordestgaard, BG; Stender, S | 1 |
Bruggeman, CA; Bruning, JH; Häyry, PJ; Lautenschlager, IT; Lemström, KB | 1 |
Baumgartner, WA; Esa, AH; Handa, N; Hatanaka, M; Herskowitz, A; Reitz, BA; Sandford, G | 1 |
Altura, BM; Altura, BT; Barbour, RL; Markell, MS | 1 |
Gudat, F; Mihatsch, MJ; Ryffel, B | 1 |
Beckingham, IJ; Blamey, RW; Dennis, MJ | 1 |
Boffa, GM; Bortolotti, U; Faggian, G; Livi, U; Luciani, GB; Mazzucco, A; Thiene, G | 1 |
Emeson, EE; Shen, ML | 1 |
Baur, R; Dartsch, PC; Höher, M; Hombach, V; Osterhues, H; Seitzer, U; Voisard, R | 1 |
Cushing, KA; Henley, SE; Larsen, JL; Mack-Shipman, L; Miller, SA; Stratta, RJ | 1 |
Arnadottir, M; Hultberg, B; Nilsson-Ehle, P; Thysell, H; Vladov, V | 1 |
Binderup, L; Häyry, P; Pakkala, I; Pakkala, S; Räisänen-Sokolowski, A; Samila, S; Vuoristo, P | 1 |
Häyry, PJ; Koskinen, PK; Lemström, KB; Räisänen-Sokolowski, AK | 1 |
Knapp, HR | 1 |
Jacobs, U; Klehr, HU; Klein, B; Miersch, WD; Molitor, D | 1 |
Binderup, L; Häyry, PJ; Pakkala, IS; Pakkala, ST; Räisänen-Sokolowski, AK; Samila, SP | 1 |
Arlt, M; Brückner, D; Dietl, KH; Hohage, H; Spieker, C; Zidek, W | 1 |
Buelow, R; Hancock, WW; Kim, KS; Murphy, B; Sayegh, MH | 1 |
Cantarovich, M; Latter, DA; Loertscher, R | 1 |
Bolli, P; Bose, R; Perry, Y; Rigatto, O; Rush, D; Walker, S | 1 |
Andersen, HO; Nordestgaard, BG; Qvortrup, K; Rostgaard, J | 1 |
Billiar, TR; Kawaharada, N; Kovesdi, I; Lizonova, A; Pham, SM; Shears, LL; Tzeng, E; Watkins, SC | 1 |
Andersen, HO; Hansen, BF; Holm, P; Nordestgaard, BG; Stender, S | 2 |
Bresson-Vautrin, C; Chalopin, JM; Ducloux, D; Fournier, V; Gibey, R; Rebibou, JM | 1 |
Accettola, F; Allegra, A; Buemi, M; Caputo, F; Corica, F; Corsonello, A; Ientile, R; Macaione, S; Sparacino, V | 1 |
Kawaharada, N; Li, S; Pham, SM; Sehgal, S; Shears, LL; Venkataramanan, R | 1 |
Hasselwander, O; Young, IS | 1 |
Dimmeler, S; Galle, J; Haendeler, J; Walter, DH; Zeiher, AM | 1 |
Arnadottir, M; Dimény, E; Fellström, B; Hultberg, B; Wahlberg, J | 1 |
Buelow, R; Denton, MD; Hancock, WW; Kim, KS; Knoflach, A; Magee, C; Sayegh, MH | 1 |
Buchdunger, E; Häyry, P; Koskinen, P; Lemström, K; Loubtchenkov, M; Myllärniemi, M; Sihvola, R | 1 |
Krämer-Guth, A; Mainka, T; Nauck, M; Quaschning, T; Rump, LC; Wanner, C | 1 |
Sata, M; Walsh, K | 1 |
Corless, CL; Loomis, CB; Orloff, SL; Rabkin, JM; Wagner, CR; Yin, Q | 1 |
Carrier, M; Daly, P; Davies, R; Gudas, V; Kostuk, W; Latter, D; Rivard, M; Sullivan, J; Teo, K; White, M | 1 |
Vanrenterghem, YF | 1 |
Illner, WD; Keunecke, C; Land, W; Rothenpieler, U; Schneeberger, H; Stangl, M; Theodorakis, J; Zanker, B | 1 |
Di Paolo, S; Morrone, LF; Resta, F; Schena, A; Schena, FP; Stallone, G | 1 |
Davidson, MH | 1 |
Enosawa, S; Lu, H; Ohmi, K; Suzuki, S | 1 |
Hillebrands, JL; Klatter, FA; Nieuwenhuis, P; Popa, ER; Rozing, J; van den Hurk, BM | 1 |
Baldwin, W; Chen, W; Hess, AD; Hruban, R; Miura, Y; Qian, Z; Sommer, M; Thoburn, CJ | 1 |
Paul, LC | 1 |
Cole, O; Rigg, K; Shehata, M | 1 |
Baldwin, WM; Hruban, RH; Hu, W; Liu, J; Qian, Z; Sanfilippo, F | 1 |
Chow, CM; Fox, ER; Ovuworie, CA; Pascual, M; Picard, MH; Shih, VE; Tolkoff-Rubin, NE | 1 |
Carpenter, M; Hirsch, G; Johnson, P; Lee, T | 1 |
Häyry, P; Mennander, A; Paavonen, T | 1 |
Hayasaka, K; Kotake, H; Naito, T; Oikawa, S; Toyota, T | 1 |
Adams, DH; Collins, JJ; Karnovsky, MJ; Tilney, NL | 1 |
Cajulis, E; Chapman, FA; Cramer, DV; Makowka, L; Starzl, TE; Wang, HK; Wu, GD | 1 |
Halttunen, J; Häyry, P; Mennander, A; Paavonen, T; Tiisala, S | 1 |
7 review(s) available for cyclosporine and Arteriosclerosis
Article | Year |
---|---|
[Ischemic tubulointerstitial injury].
Topics: Acute Disease; Antiphospholipid Syndrome; Arteriosclerosis; Calcineurin Inhibitors; Chronic Disease; Contrast Media; Cyclosporine; Humans; Infarction; Ischemia; Kidney Cortex Necrosis; Kidney Diseases; Renal Artery | 2011 |
[Risk of atherosclerosis development in patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Arteriosclerosis; Autoantibodies; Azathioprine; Blood Coagulation Disorders; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Disease Progression; Female; Humans; Lupus Erythematosus, Systemic; Myocardial Infarction; Risk Factors | 2005 |
Infections in heart transplant recipients.
Topics: Anti-Bacterial Agents; Arteriosclerosis; Central Nervous System Diseases; Cyclosporine; Cytomegalovirus Infections; Heart Transplantation; Heart-Assist Devices; Humans; Infections; Lymphoproliferative Disorders; Pneumonia; Time Factors; Tissue Donors | 1994 |
n-3 fatty acids and human hypertension.
Topics: Antihypertensive Agents; Arteriosclerosis; Blood Pressure; Controlled Clinical Trials as Topic; Cyclosporine; Diabetes Complications; Fatty Acids, Omega-3; Humans; Hypertension | 1996 |
Oxidative stress in chronic renal failure.
Topics: Animals; Antioxidants; Arteriosclerosis; Cyclosporine; Free Radicals; Humans; Hyperlipidemias; Kidney Failure, Chronic; Kidney Transplantation; Lipoproteins, LDL; Lipoproteins, VLDL; Oxidation-Reduction; Oxidative Stress | 1998 |
Which calcineurin inhibitor is preferred in renal transplantation: tacrolimus or cyclosporine?
Topics: Arteriosclerosis; Calcineurin Inhibitors; Cyclosporine; Diabetes Mellitus; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Tacrolimus; Time Factors | 1999 |
Does differing metabolism by cytochrome p450 have clinical importance?
Topics: Anticoagulants; Arteriosclerosis; Calcium Channel Blockers; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Hypolipidemic Agents; Immunosuppressive Agents; Mixed Function Oxygenases; Niacin; Polymorphism, Genetic; Risk Factors; Warfarin | 2000 |
8 trial(s) available for cyclosporine and Arteriosclerosis
Article | Year |
---|---|
Diabetogenicity of FK506 versus cyclosporine in liver transplant recipients.
Topics: Adult; Arteriosclerosis; Cyclosporine; Diabetes Mellitus; Dose-Response Relationship, Drug; Female; Glucose Tolerance Test; Graft Rejection; Humans; Liver Transplantation; Male; Middle Aged; Risk Factors; Tacrolimus | 1994 |
The effects of cyclosporine and prednisone on serum lipid and (apo)lipoprotein levels in renal transplant recipients.
Topics: Adult; Apolipoproteins; Arteriosclerosis; Azathioprine; Cholesterol, HDL; Cyclosporine; Female; Graft Rejection; Humans; Hyperlipidemias; Hypertension; Kidney Diseases; Kidney Transplantation; Lipids; Lipoproteins; Male; Middle Aged; Obesity; Postoperative Complications; Prednisone; Prospective Studies; Proteinuria; Risk; Risk Factors | 1995 |
Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
Topics: Adolescent; Adult; Aged; Anticholesteremic Agents; Arteriosclerosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Creatine Kinase; Creatinine; Cyclosporine; Drug Interactions; Fatty Acids, Monounsaturated; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Indoles; Kidney Transplantation; Middle Aged; Placebos; Safety; Single-Blind Method; Triglycerides | 1995 |
Coronary vasculopathy following cardiac transplantation and cyclosporine immunosuppression: preventive treatment with angiopeptin, a somatostatin analog.
Topics: Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Coronary Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Oligopeptides; Peptides, Cyclic; Postoperative Complications; Prednisolone; Prospective Studies; Somatostatin | 1994 |
Lipids following pancreas transplantation in recipients receiving FK 506.
Topics: Adult; Arteriosclerosis; Cyclosporine; Diabetes Mellitus, Type 1; Female; Humans; Lipids; Male; Pancreas Transplantation; Risk Factors; Tacrolimus | 1995 |
Cholesterol reduction in cyclosporine-treated renal transplant patients: effect on platelet-derived growth factor levels and platelet activation.
Topics: Arteriosclerosis; Cholesterol; Cyclosporine; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Platelet Activation; Platelet-Derived Growth Factor; Transplantation, Homologous | 1997 |
Immunosuppression enhances atherogenicity of lipid profile after transplantation.
Topics: Apolipoproteins B; Arteriosclerosis; Azathioprine; Cholesterol, VLDL; Cyclosporine; Drug Therapy, Combination; Female; Humans; Hypertriglyceridemia; Immunosuppressive Agents; Kidney Transplantation; Lipids; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Prednisone; Sex Factors; Treatment Outcome; Triglycerides | 1999 |
Mycophenolate mofetil monotherapy: an example of a safe nephrotoxicity/atherogenicity-free immunosuppressive maintenance regimen in a selected group of kidney-transplanted patients.
Topics: Adult; Arteriosclerosis; Cyclosporine; Female; Graft Rejection; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Mycophenolic Acid; Pilot Projects; Safety | 2000 |
69 other study(ies) available for cyclosporine and Arteriosclerosis
Article | Year |
---|---|
Two distinct FSGS lesions caused by distinct etiology confirmed in a single patient in pre- and post-transplantation.
Topics: Arteriosclerosis; Child, Preschool; Cyclosporine; Glomerulosclerosis, Focal Segmental; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Male; Middle Aged; Nephrotic Syndrome; Proteinuria; Recurrence; Treatment Outcome; Vesico-Ureteral Reflux | 2010 |
[Effect of cyclosporin and tacrolimus on lipoprotein oxidation after renal transplantation].
Topics: Adult; Antihypertensive Agents; Apolipoproteins B; Arteriosclerosis; Azathioprine; Cholesterol; Cyclosporine; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Oxidation-Reduction; Oxidative Stress; Prednisone; Retrospective Studies; Tacrolimus; Triglycerides | 2002 |
Impact of changing immunosuppressive monotherapy from Cyclosporin A to Tacrolimus in long-term, stable liver transplant recipients.
Topics: Arteriosclerosis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Lipids; Liver; Liver Transplantation; Male; Middle Aged; Postoperative Period; Retreatment; Tacrolimus; Time Factors | 2004 |
Effect of conversion from cyclosporine A to mizoribine on transplant arteriosclerosis in rat aortic allograft models.
Topics: Animals; Aorta; Arteriosclerosis; Cyclosporine; Hyperplasia; Immunosuppressive Agents; Male; Models, Animal; Rats; Rats, Inbred Lew; Ribonucleosides; Transplantation Immunology; Tunica Intima | 2003 |
Influence of recipient family history of atherosclerosis of renal allograft outcome.
Topics: Arteriosclerosis; Blood Pressure; Cyclosporine; Drug Therapy, Combination; Family; Follow-Up Studies; Histocompatibility Testing; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Medical History Taking; Retrospective Studies; Time Factors; Treatment Outcome | 2003 |
Dissociation between carotid artery lesions and lipid parameters in recipients of successful kidney graft.
Topics: Adult; Arteriosclerosis; Body Mass Index; Carotid Arteries; Carotid Artery Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Triglycerides; Ultrasonography | 2003 |
Insights into cyclosporine A-induced atherosclerotic risk in transplant recipients: macrophage scavenger receptor regulation.
Topics: Arteriosclerosis; Cell Line; Cyclosporine; Dose-Response Relationship, Drug; Down-Regulation; Gene Expression Regulation; Humans; Immunosuppressive Agents; Lysosomal Membrane Proteins; Macrophages; Membrane Proteins; Organ Transplantation; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, Lipoprotein; Receptors, Scavenger; Risk Factors; RNA, Messenger; Scavenger Receptors, Class B; Sialoglycoproteins; Time Factors; Up-Regulation | 2004 |
Effect of tacrolimus on the expression of macrophage scavenger and nuclear hormone receptors in THP-1-derived human macrophages.
Topics: Antigens, CD; Antigens, Differentiation, Myelomonocytic; Arteriosclerosis; ATP Binding Cassette Transporter 1; ATP-Binding Cassette Transporters; CD36 Antigens; Cell Line; Cyclosporine; Gene Expression; Humans; Immunosuppressive Agents; Macrophages; Receptors, Cytoplasmic and Nuclear; Receptors, Immunologic; Receptors, LDL; Receptors, Scavenger; RNA, Messenger; Scavenger Receptors, Class A; Tacrolimus | 2004 |
Reduced intragraft mRNA expression of matrix metalloproteinases Mmp3, Mmp12, Mmp13 and Adam8, and diminished transplant arteriosclerosis in Ccr5-deficient mice.
Topics: ADAM Proteins; Animals; Antigens, CD; Arteriosclerosis; Carotid Arteries; Collagenases; Cyclosporine; Heart Transplantation; Matrix Metalloproteinase 12; Matrix Metalloproteinase 13; Matrix Metalloproteinase 3; Membrane Proteins; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oligonucleotide Array Sequence Analysis; Receptors, CCR5; RNA, Messenger; Transplantation, Homologous | 2004 |
Conversion from cyclosporine A to mycophenolate mofetil protects recipient kidney and prevents intimal hyperplasia in rat aortic allografts.
Topics: Animals; Aorta, Abdominal; Apoptosis; Arteriosclerosis; Cyclosporine; Hyperplasia; Immunosuppressive Agents; Kidney; Macrophages; Male; Mycophenolic Acid; Rats; Rats, Inbred Lew; T-Lymphocytes; Transplantation, Homologous; Tunica Intima; Weight Loss | 2004 |
Two distinct calcium-dependent mitochondrial pathways are involved in oxidized LDL-induced apoptosis.
Topics: Apoptosis; Apoptosis Inducing Factor; Arteriosclerosis; BH3 Interacting Domain Death Agonist Protein; Calcium; Calpain; Carrier Proteins; Caspase 3; Caspase Inhibitors; Caspases; Cells, Cultured; Cyclosporine; Cysteine Proteinase Inhibitors; Cytochromes c; Endothelium, Vascular; Flavoproteins; Humans; Immunosuppressive Agents; Lipoproteins, LDL; Membrane Proteins; Microcirculation; Mitochondria; Tacrolimus | 2005 |
Classic lamellar proteinaceous medial hyalinosis of small arteries and arterioles seen in an allograft without cyclosporine exposure.
Topics: Adult; Arteries; Arterioles; Arteriosclerosis; Cyclosporine; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Transplantation, Homologous | 2005 |
Rheological properties of red blood cells in kidney transplant recipients: the role of lipid profile and type of immunosuppresion.
Topics: Adult; Arteriosclerosis; Creatinine; Cyclosporine; Erythrocytes; Female; Hematocrit; Humans; Hyperlipidemias; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Middle Aged; Postoperative Complications; Rheology; Risk Factors; Tacrolimus | 2005 |
Cardiac allograft atherosclerosis in the rat. The effect of histocompatibility factors, cyclosporine, and an angiotensin-converting enzyme inhibitor.
Topics: Animals; Arteriosclerosis; Cilazapril; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Heart Transplantation; Male; Neovascularization, Pathologic; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
How cyclosporine modifies histological and molecular events in the vascular wall during chronic rejection of rat cardiac allografts.
Topics: Animals; Arteriosclerosis; Blood Vessels; Cell Adhesion Molecules; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Heart Transplantation; Immunoenzyme Techniques; Immunosuppression Therapy; Rats; Rats, Inbred Strains; Rats, Inbred WF; Transplantation, Homologous; Vascular Cell Adhesion Molecule-1 | 1995 |
Relative importance of ischemic injury and immunological injury on the development of transplant arteriosclerosis in rabbit aortic allografts.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Body Weight; Cholesterol; Cyclosporine; Immunosuppressive Agents; Ischemia; Lipoproteins; Male; Rabbits; T-Lymphocytes; Time Factors; Transplantation, Homologous; Tunica Intima | 1995 |
Cyclosporine treatment reduces early atherosclerosis in the cholesterol-fed rabbit.
Topics: Animals; Arteriosclerosis; Cell Division; Cholesterol; Cyclosporine; Diet, Atherogenic; Disease Models, Animal; Immunoglobulins; Immunosuppressive Agents; Injections, Intramuscular; Leukocyte Count; Macrophages; Male; Rabbits; T-Lymphocytes, Helper-Inducer | 1995 |
Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cholesterol, Dietary; Cyclosporine; Diet, Atherogenic; Graft Survival; Immunity, Cellular; Immunohistochemistry; Immunosuppression Therapy; Kinetics; Lipoproteins; Macrophages; Male; Rabbits; Skin Transplantation; Time Factors; Transplantation, Homologous | 1995 |
Atherogenic effects of cyclosporine in an experimental model of arterial autograft.
Topics: Animals; Arteries; Arteriosclerosis; Cyclosporine; Female; Hyperplasia; Immunosuppressive Agents; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Transplantation, Autologous | 1995 |
Efficacy of cyclosporine and angiotensin-converting enzyme inhibitor to inhibit cardiac graft atherosclerosis in the rat.
Topics: Animals; Arteriosclerosis; Cilazapril; Cyclosporine; Factor Analysis, Statistical; Heart Transplantation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterotopic; Transplantation, Homologous; Transplantation, Isogeneic | 1994 |
Suppression of acute rejection prevents graft arteriosclerosis after allogeneic aorta transplantation in the rat.
Topics: Animals; Aorta; Arteriosclerosis; Cyclosporine; Graft Rejection; Immunosuppressive Agents; Male; Polyenes; Rats; Rats, Inbred BN; Rats, Inbred Strains; Sirolimus; Transplantation, Autologous; Transplantation, Homologous | 1994 |
Cyclosporin suppresses experimental transplant atherosclerosis.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Cholesterol, Dietary; Cyclosporine; Humans; Muscle, Smooth, Vascular; Rabbits | 1994 |
Ischemic injury and experimental transplantation atherosclerosis.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cholesterol; Cyclosporine; Ischemia; Rabbits; Reperfusion Injury; Transplantation, Homologous; Vascular Surgical Procedures | 1994 |
Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages.
Topics: Aged; Arteriosclerosis; Cells, Cultured; Cholestanetriol 26-Monooxygenase; Cholesterol; Cyclosporine; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Female; Humans; Hydroxycholesterols; In Vitro Techniques; Macrophages, Alveolar; Male; Middle Aged; Steroid Hydroxylases | 1994 |
Cyclosporin suppresses transplant arteriosclerosis in the aorta-allografted, cholesterol-clamped rabbit. Suppression preceded by decrease in arterial lipoprotein permeability.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Cell Membrane Permeability; Cholesterol; Cyclosporine; Heart Transplantation; Immunosuppressive Agents; Lipoproteins; Male; Rabbits; Transplantation, Heterotopic | 1994 |
Triple drug immunosuppression significantly reduces immune activation and allograft arteriosclerosis in cytomegalovirus-infected rat aortic allografts and induces early latency of viral infection.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Azathioprine; Cell Division; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA; DNA, Viral; Graft Rejection; Histocompatibility Antigens Class II; Immunity; Immunohistochemistry; Immunosuppression Therapy; Immunosuppressive Agents; Incidence; Killer Cells, Natural; Methylprednisolone; Muscle, Smooth, Vascular; Rats; Rats, Inbred WF; Reaction Time; Receptors, Interleukin-2; T-Lymphocytes; Thymidine; Transplantation, Homologous; Tritium | 1994 |
Late cyclosporine treatment ameliorates established coronary graft disease in rat allografts.
Topics: Animals; Arteriosclerosis; Cyclosporine; Cytomegalovirus Infections; Graft Rejection; Heart Transplantation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors; Transplantation, Homologous | 1993 |
Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.
Topics: Adult; Arteriosclerosis; Calcium; Cholesterol; Creatinine; Cyclosporine; Female; Humans; Immunosuppression Therapy; Ions; Kidney Transplantation; Magnesium Deficiency; Male; Middle Aged; Time Factors | 1993 |
Morphological criteria of chronic rejection: differential diagnosis, including cyclosporine nephropathy.
Topics: Arteries; Arterioles; Arteriosclerosis; Chronic Disease; Cyclosporine; Diagnosis, Differential; Graft Rejection; Humans; Kidney Glomerulus; Kidney Transplantation; Kidney Tubules; Muscle, Smooth, Vascular; Renal Circulation | 1993 |
Evaluation of animal models of chronic vascular rejection.
Topics: Animals; Arteriosclerosis; Atrophy; Chronic Disease; Cyclosporine; Disease Models, Animal; Fibrosis; Graft Rejection; Hyperplasia; Ischemia; Kidney Transplantation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Rats, Wistar; Renal Circulation | 1993 |
Clinical results of steroid-free induction immunosuppression after heart transplantation.
Topics: Adolescent; Adult; Aged; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Bacterial Infections; Child; Child, Preschool; Cyclosporine; Female; Graft Occlusion, Vascular; Graft Rejection; Heart; Heart Transplantation; Humans; Immunosuppression Therapy; Infant; Male; Middle Aged; Muromonab-CD3; Prednisone; Retrospective Studies; Survival Rate; Treatment Outcome | 1993 |
Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A.
Topics: Animals; Aorta; Arteriosclerosis; Carotid Arteries; Cholesterol; Cyclosporine; Diet, Atherogenic; Female; Hyperlipidemias; Injections, Subcutaneous; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Liver; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Skin Transplantation; Time Factors; Transplantation, Homologous | 1993 |
A prescreening system for potential antiproliferative agents: implications for local treatment strategies of postangioplasty restenosis.
Topics: Actins; Adult; Aged; Aged, 80 and over; Angioplasty, Balloon; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Arteriosclerosis; Cell Division; Cells, Cultured; Colchicine; Cyclosporine; Dalteparin; Doxorubicin; Drug Evaluation, Preclinical; Etoposide; Female; Femoral Artery; Fibrinolytic Agents; Gout Suppressants; Humans; Immunosuppressive Agents; Male; Microtubules; Middle Aged; Muscle, Smooth, Vascular; Recurrence; Vimentin | 1995 |
Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.
Topics: Adult; Aged; Arteriosclerosis; Case-Control Studies; Cross-Sectional Studies; Cyclosporine; Erythrocytes; Female; Folic Acid; Glomerular Filtration Rate; Homocysteine; Homocystinuria; Humans; Kidney Transplantation; Male; Middle Aged; Risk Factors | 1996 |
Effect of MC1288, a vitamin D analogue, on lymphocyte proliferation in vitro and rat aortic allograft arteriosclerosis in vivo.
Topics: Animals; Aorta; Arteriosclerosis; Calcitriol; CD4 Antigens; CD8 Antigens; Cyclosporine; Gene Expression; Growth Substances; Immunosuppressive Agents; Lymphocyte Activation; Polymerase Chain Reaction; Rats; Receptors, Interleukin-2; RNA, Messenger; Stereoisomerism; Transplantation, Homologous | 1996 |
Triple drug immunosuppression significantly reduces aortic allograft arteriosclerosis in the rat.
Topics: Animals; Aorta; Aortic Diseases; Arteriosclerosis; Azathioprine; Cell Division; Cyclosporine; Down-Regulation; Drug Therapy, Combination; Graft Rejection; Immunohistochemistry; Immunosuppressive Agents; Methylprednisolone; Rats; Rats, Inbred Strains; Rats, Inbred WF; Regression Analysis; Transplantation, Heterologous; Vasculitis | 1996 |
Dilemma: maintenance therapy enhances sclerogenic risk profile.
Topics: Adult; Age Factors; Aged; Antihypertensive Agents; Arteriosclerosis; Azathioprine; Cholesterol; Cortisone; Cyclosporine; Diabetes Mellitus; Follow-Up Studies; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Lipoproteins; Middle Aged; Postoperative Complications; Risk Factors; Time Factors; Triglycerides; Weight Gain | 1996 |
A vitamin D analog, MC1288, inhibits adventitial inflammation and suppresses intimal lesions in rat aortic allografts.
Topics: Animals; Aorta; Aortic Diseases; Arteriosclerosis; Cyclosporine; Drug Therapy, Combination; Graft Rejection; Hypercalcemia; Immunosuppressive Agents; Lymphocyte Culture Test, Mixed; Muscle, Smooth, Vascular; Rats; Rats, Inbred WF; Transplantation, Homologous; Tunica Intima; Vitamin D | 1997 |
Effects of cyclosporin A and FK 506 on lipid metabolism and fibrinogen in kidney transplant recipients.
Topics: Adult; Age Factors; Arteriosclerosis; Blood Glucose; Body Weight; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cyclosporine; Fasting; Female; Fibrinogen; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Lipid Metabolism; Lipids; Male; Prednisolone; Risk Factors; Sex Factors; Tacrolimus; Transplantation, Homologous; Triglycerides | 1997 |
Synthetic MHC class I peptide prolongs cardiac survival and attenuates transplant arteriosclerosis in the Lewis-->Fischer 344 model of chronic allograft rejection.
Topics: Animals; Arteriosclerosis; Chronic Disease; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Heart Transplantation; HLA-B Antigens; Immunosuppressive Agents; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1997 |
Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Topics: Acute Disease; Antilymphocyte Serum; Arteriosclerosis; Azathioprine; Bacterial Infections; Biopsy; Cost-Benefit Analysis; Cyclosporine; Drug Administration Schedule; Drug Resistance; Female; Follow-Up Studies; Glucocorticoids; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Incidence; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Prednisone; Randomized Controlled Trials as Topic; Recurrence; Survival Rate; Treatment Outcome | 1997 |
Effect of cyclosporine during initiation of transplant arteriosclerosis. An ultrastructural study in the aorta-transplanted rabbit.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Arteriosclerosis; Body Weight; Cholesterol; Cyclosporine; Endothelium; Graft Rejection; Immunosuppressive Agents; Male; Microscopy; Microscopy, Electron; Microscopy, Electron, Scanning; Pharmaceutical Vehicles; Rabbits; Transplantation, Homologous | 1997 |
Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Cyclosporine; Genetic Therapy; Graft Rejection; Histocompatibility Antigens; Hyperplasia; Immunosuppressive Agents; Nitric Oxide; Nitric Oxide Synthase; Organ Transplantation; Rats; Rats, Wistar; Transplantation, Homologous; Tunica Intima | 1997 |
Dose-dependent suppression of transplant arteriosclerosis in aorta-allografted, cholesterol-clamped rabbits. Suppression not eliminated by the cholesterol-raising effect of cyclosporine.
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Diseases; Arteriosclerosis; Blood Vessel Prosthesis Implantation; Cholesterol; Cholesterol, Dietary; Cyclosporine; Dose-Response Relationship, Drug; Humans; Hypercholesterolemia; Immunosuppressive Agents; Male; Rabbits; Transplantation, Heterotopic; Transplantation, Homologous; Triiodothyronine | 1997 |
Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
Topics: Arteriosclerosis; Case-Control Studies; Creatinine; Cyclosporine; Female; Folic Acid; Homocysteine; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Risk Factors; Vitamin B 12 | 1998 |
Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
Topics: Arteriosclerosis; Azathioprine; Blood Platelets; Cyclosporine; Erythrocytes; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Magnesium; Male; Prednisolone | 1998 |
High local production of nitric oxide as a possible mechanism by which rapamycin prevents transplant arteriosclerosis.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Cyclosporine; Enzyme Induction; Immunosuppressive Agents; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Polyenes; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred WF; Sirolimus; Transplantation, Homologous; Transplantation, Isogeneic | 1998 |
Cyclosporin A inhibits apoptosis of human endothelial cells by preventing release of cytochrome C from mitochondria.
Topics: Apoptosis; Arteriosclerosis; Cells, Cultured; Cyclosporine; Cytochrome c Group; Endothelium, Vascular; Humans; Immunosuppressive Agents; Intracellular Membranes; Lipoproteins, LDL; Mitochondria; Permeability | 1998 |
Serum total homocysteine concentration before and after renal transplantation.
Topics: Adult; Aged; Arteriosclerosis; Case-Control Studies; Cyclosporine; Female; Glomerular Filtration Rate; Homocysteine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Risk Factors; Time Factors | 1998 |
Immunomodulatory functions of hyaluronate in the LEW-to-F344 model of chronic cardiac allograft rejection.
Topics: Animals; Arteriosclerosis; Cyclosporine; Graft Rejection; Heart Transplantation; Hyaluronan Receptors; Hyaluronic Acid; Immunohistochemistry; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1999 |
Prevention of cardiac allograft arteriosclerosis by protein tyrosine kinase inhibitor selective for platelet-derived growth factor receptor.
Topics: Animals; Arteriosclerosis; Cell Division; Cells, Cultured; Cyclosporine; Enzyme Inhibitors; Heart Transplantation; Interleukin-1; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Rats; Rats, Inbred WF; Receptors, Platelet-Derived Growth Factor; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 1999 |
Effect of cyclosporine on arterial balloon injury lesions in cholesterol-clamped rabbits: T lymphocyte-mediated immune responses not involved in balloon injury-induced neointimal proliferation.
Topics: Animals; Arteriosclerosis; Catheterization; Cell Division; Cholesterol; Cyclosporine; Endothelium, Vascular; Intercellular Adhesion Molecule-1; Male; Muscle, Smooth, Vascular; Rabbits; T-Lymphocytes; Vascular Cell Adhesion Molecule-1 | 1999 |
Cyclosporine downregulates Fas ligand expression on vascular endothelial cells: implication for accelerated vasculopathy by immunosuppressive therapy.
Topics: Arteriosclerosis; Cyclosporine; Down-Regulation; Endothelium, Vascular; Fas Ligand Protein; Immunosuppressive Agents; Membrane Glycoproteins; Organ Transplantation; Tacrolimus | 1999 |
A rat small bowel transplant model of chronic rejection: histopathologic characteristics.
Topics: Animals; Arteriosclerosis; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclosporine; Disease Models, Animal; Fibrosis; Graft Rejection; Graft Survival; Histocompatibility Antigens Class II; Immunohistochemistry; Intestine, Small; Macrophages; Male; Mesenteric Vascular Occlusion; Mesentery; Muscle, Smooth, Vascular; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors | 1999 |
The Canadian Study of Cardiac Transplantation. Atherosclerosis. Investigators of the CASCADE Study.
Topics: Adult; Antihypertensive Agents; Arteriosclerosis; Aspirin; Cardiovascular Agents; Cyclosporine; Cytomegalovirus Infections; Diltiazem; Female; Follow-Up Studies; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Postoperative Care; Postoperative Complications | 1999 |
Are lipid-dependent indicators of cardiovascular risk affected by renal transplantation?
Topics: Adolescent; Adult; Age Factors; Apolipoprotein A-I; Apolipoproteins B; Arteriosclerosis; Body Mass Index; Case-Control Studies; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Creatinine; Cyclosporine; Female; Humans; Hyperlipoproteinemias; Immunosuppressive Agents; Incidence; Kidney Transplantation; Linear Models; Lipoprotein(a); Lipoproteins; Male; Middle Aged; Risk Factors; Sex Factors; Triglycerides | 2000 |
The proliferative response of p53 knock-out mouse-derived vascular smooth muscle cell line, P53LMAC01, to PDGF, when compared with human aortic smooth muscle cells.
Topics: Animals; Aorta; Arteriosclerosis; Cell Division; Cell Line; Culture Media, Serum-Free; Cyclosporine; DNA Replication; Genes, p53; Graft Rejection; Heart Transplantation; Humans; Hyperplasia; Mice; Mice, Knockout; Models, Animal; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Species Specificity; Tumor Suppressor Protein p53 | 2001 |
Origin of neointimal endothelium and alpha-actin-positive smooth muscle cells in transplant arteriosclerosis.
Topics: Actins; Animals; Aorta; Arteriosclerosis; Cyclosporine; Female; Genes, MHC Class I; Heart Transplantation; Humans; Immunohistochemistry; Immunosuppressive Agents; Male; Muscle, Smooth, Vascular; Polymerase Chain Reaction; Rats; Rats, Inbred Strains; Transplantation; Tunica Intima | 2001 |
Autoimmune-mediated vasculopathy.
Topics: Adoptive Transfer; Animals; Antigens, Differentiation, B-Lymphocyte; Arteriosclerosis; Autoimmune Diseases; Chloroquine; Cyclosporine; Cytotoxicity, Immunologic; Disease Progression; Female; Graft Rejection; Graft vs Host Disease; Heart Transplantation; Histocompatibility Antigens Class II; Immunosuppressive Agents; Lymphocyte Depletion; Lymphokines; Macromolecular Substances; Postoperative Complications; Radiation Chimera; Rats; Rats, Inbred Lew; T-Lymphocytes; Th1 Cells; Th2 Cells; Thymectomy; Transplantation, Isogeneic; Tunica Intima; Tunica Media; Vasculitis | 2001 |
Endothelial dysfunction, atherosclerosis and cyclosporine in renal transplantation.
Topics: Arteriosclerosis; Cyclosporine; Endothelium, Vascular; Humans; Immunosuppressive Agents; Kidney Transplantation; P-Selectin; Platelet Aggregation; von Willebrand Factor | 2001 |
The effect of different immunosuppressants on alloantigen dependent and independent factors involved in the development of chronic rejection in an animal model.
Topics: Animals; Aorta, Abdominal; Arteriosclerosis; Chronic Disease; Cyclosporine; Disease Models, Animal; Everolimus; Graft Rejection; Immunosuppressive Agents; Isoantigens; Male; Mycophenolic Acid; Rats; Rats, Inbred F344; Rats, Inbred Lew; Sirolimus; Tacrolimus | 2001 |
Accelerated graft arteriosclerosis in cardiac transplants: complement activation promotes progression of lesions from medium to large arteries.
Topics: Animals; Animals, Congenic; Arteriosclerosis; Complement C6; Complement Membrane Attack Complex; Cyclosporine; Female; Graft Rejection; Heart Transplantation; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; Isoantibodies; Male; Rats; Transplantation, Homologous | 2001 |
Vascular endothelial function in cyclosporine and tacrolimus treated renal transplant recipients.
Topics: Adult; Arteriosclerosis; Cyclosporine; Endothelium, Vascular; Female; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Risk Factors; Tacrolimus; Vasodilation | 2001 |
Recipient cells form the intimal proliferative lesion in the rat aortic model of allograft arteriosclerosis.
Topics: Animals; Aorta; Arteriosclerosis; Base Sequence; Cyclosporine; Disease Models, Animal; DNA Primers; Histocompatibility Antigens; Immunosuppressive Agents; Major Histocompatibility Complex; Male; Molecular Sequence Data; Rats; Rats, Inbred BN; Rats, Inbred Lew; Sequence Alignment; Transplantation, Homologous; Tunica Intima | 2002 |
Cyclosporine-induced endothelialitis and accelerated arteriosclerosis in chronic allograft rejection.
Topics: Animals; Aorta; Arteriosclerosis; Azathioprine; Cyclosporine; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Methylprednisolone; Rats; Rats, Inbred Strains; Rats, Inbred WF; Retrospective Studies; Transplantation, Homologous; Transplantation, Isogeneic | 1992 |
T lymphocytes increase the synthesis of esterified cholesterol in human monocyte-derived macrophages by activation of the scavenger pathway.
Topics: Arteriosclerosis; Cells, Cultured; Cholesterol Esters; Cyclosporine; Foam Cells; Humans; Lipoproteins, LDL; Lymphokines; T-Lymphocytes | 1992 |
Experimental graft arteriosclerosis. I. The Lewis-to-F-344 allograft model.
Topics: Animals; Arteries; Arteriosclerosis; Cyclosporine; Disease Models, Animal; Graft Rejection; Graft Survival; Heart Transplantation; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1992 |
FK 506 inhibits the development of transplant arteriosclerosis.
Topics: Animals; Arteriosclerosis; Cyclosporine; Heart Transplantation; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew; Tacrolimus; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1991 |
Chronic rejection of rat aortic allograft. II. Administration of cyclosporin induces accelerated allograft arteriosclerosis.
Topics: Animals; Aorta, Thoracic; Arteriosclerosis; Azathioprine; Cyclosporine; Disease Models, Animal; Drug Therapy, Combination; Endothelium, Vascular; Graft Rejection; Humans; Immunoenzyme Techniques; Immunosuppression Therapy; Methylprednisolone; Muscle, Smooth, Vascular; Rats; Time Factors; Transplantation, Homologous | 1991 |